Twinbeech Capital LP Eli Lilly & CO Transaction History

Twinbeech Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $3.8 Million - $5.09 Million	6,419 New	6,419 $4.99 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $3.72 Million - $4.37 Million	-13,352 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $3.13 Million - $3.89 Million	13,352 New	13,352 $3.82 Million

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.